Search references for CENDAKIMAB. Phrases containing CENDAKIMAB
See searches and references containing CENDAKIMAB!CENDAKIMAB
Pharmaceutical compound
Cendakimab (RPC4046; ABT 308; CC-93538) is a monoclonal antibody against interleukin 13. It is developed by Bristol Myers Squibb for eosinophilic esophagitis
Cendakimab
Protein and coding gene in humans
dupilumab may be an effective form of treatment for asthmatic patients. Cendakimab is also a monoclonal antibody to the IL-13 receptor. Interleukin-13 receptor
Interleukin_13
Pharmaceutical drug classification
Bimekizumab L04AC22 Spesolimab L04AC23 Olokizumab L04AC26 Goflikicept L04AC27 Cendakimab L04AD01 Ciclosporin L04AD02 Tacrolimus L04AD03 Voclosporin L04AE01 Fingolimod
ATC_code_L04
travel, tourism, insurance
CENDAKIMAB
CENDAKIMAB
CENDAKIMAB
CENDAKIMAB
CENDAKIMAB
CENDAKIMAB
CENDAKIMAB
CENDAKIMAB
CENDAKIMAB
travel, tourism, insurance